Eikon
PrivateLast Round
IPO
2/4/2026
Est. Valuation
$900M
Total Funding Raised
$1.1B
Company Overview
Eikon Therapeutics is a biotechnology company that operates a drug discovery and development platform designed to provide innovative treatments for life-threatening diseases by enabling the sensitive identification of compounds-protein interactions in live cellular environments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eikon Comps
Public and private peers based on sector, stage, and business model.
Eikon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | 2/4/2026 | ||||
| Series D | 2/26/2025 | ||||
| Series C | 6/1/2023 | ||||
| Series B | 1/6/2022 | ||||
| Series A | 5/5/2021 |
Key People
Founding team and executive leadership
Eikon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B |
| The Column Group | Series B, Series A, Series D |
| CPP Investments | Series B |
| Horizons Ventures | Series B |
| Innovation Endeavors | Series B, Series A |
| E15 VC | Series D, Series B |
| Soros Capital Management | Series B, Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2026
$381M raised in IPO round.
- Oct 16, 2025
Preparing for pivotal Phase II/III trial for EIK1001 in advanced NSCLC.
Eikon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eikon's valuation, stock price, and market status.
